Company Overview
Lightwave Logic, Inc. is dedicated to the development and commercialization of electro-optic polymer materials specifically designed for data communications and various photonic applications within the United States and international markets. The company operates within the Basic Materials sector, focusing on the Specialty Chemicals industry, which involves the production of specialized compounds that are essential for advanced technological integration. This entity holds a market capitalization of $1.07 billion and reported trailing twelve-month revenue of $236,855, while the specific employee count is not disclosed in available records. The disparity between a market capitalization exceeding one billion dollars and a revenue figure under three hundred thousand dollars suggests a significant valuation premium relative to current earnings power, indicating that the market price primarily reflects future growth expectations in the silicon photonics integration space rather than current operational scale or profitability.
Financial Health
The company reported trailing twelve-month revenue of $236,855, yet recorded a net income of -$20,313,796 and an EBITDA of -$18,858,056, revealing a substantial gap where expenses significantly exceed revenue generation. This negative net income relative to positive revenue indicates a cost structure where operating costs, likely including heavy R&D expenditures for material development, have not yet been covered by sales, resulting in a net loss. Free cash flow stands at -$12,705,287, which signifies that the company is currently burning cash to fund its operations and development efforts, implying limited financial flexibility for immediate expansion or acquisitions without additional capital infusion. The margin profile is characterized by a gross margin of 97.1%, an operating margin of -2982.5%, and a profit margin of 0.0%, illustrating that while the core product sales are highly profitable before overheads, operating expenses are so high that they negate all gross profit. On the balance sheet, the company holds $69.02 million in cash against only $2.60 million in debt, creating a liquidity cushion that far exceeds its obligations. The debt-to-equity ratio is 3.48, which mathematically appears leveraged but is heavily mitigated by the massive cash hoard, suggesting the company is not in a distressed debt position despite the negative equity implied by losses. The current ratio of 32.69 indicates an exceptionally strong short-term liquidity position, as current assets are more than thirty-two times greater than current liabilities. Return on Equity is -37.6% and Return on Assets is -22.2%, metrics that reveal management has not yet achieved positive returns on shareholder capital or deployed assets, a common characteristic in early-stage technology development companies.
Valuation Assessment
Trailing P/E and forward P/E ratios are both listed as N/A, which implies that traditional earnings-based valuation models are currently inapplicable due to the company's negative net income and lack of positive earnings trajectory in the trailing period. The price-to-book ratio is 14.38, indicating that the stock is trading at a significant premium of over fourteen times its net asset value, a metric often seen in companies with intangible assets like intellectual property that are not fully captured on the balance sheet. Alternative valuation metrics such as the price-to-sales ratio of 4512.95 and an EV/EBITDA of -54.48 further illustrate that the stock is priced on speculative future potential rather than current sales or earnings performance. The 52-week high is $8.04 and the 52-week low is $0.79, placing the current trading context within a wide historical range that reflects high volatility and investor sentiment shifts regarding the silicon photonics sector. The beta value is N/A, meaning that the stock's historical volatility relative to the broader market is not quantifiable through standard regression analysis, likely due to the low trading volume or lack of sufficient price history compared to large-cap peers.
Growth & Income
Revenue growth year-over-year is 594.5%, while earnings growth is N/A, indicating that top-line sales have expanded dramatically while profitability remains non-existent or negative. The absence of earnings growth data alongside massive revenue growth suggests that the company is in a revenue-acquisition phase where increased sales volume has not yet translated into net income, likely due to the high fixed costs and R&D investments inherent in the specialty chemical industry. As a non-dividend payer with a dividend yield of N/A and a payout ratio of 0.0%, the company reinvests all available earnings back into research, development, and commercialization efforts rather than distributing income to shareholders. The overall growth and income profile is defined by explosive revenue expansion coupled with significant cash consumption and zero current profitability, positioning the stock as a high-risk, high-potential speculative asset dependent on future product commercialization success.